RIGEL PHARMACEUTICALS, INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2009 | — | $-112.0M | $-111.5M |
| FY2010 | — | $35.3M | $37.9M |
| FY2011 | — | $-86.4M | $-86.0M |
| FY2012 | — | $-99.4M | $-98.8M |
| FY2013 | — | $-89.5M | $-89.0M |
| FY2014 | — | $-91.2M | $-90.9M |
| FY2015 | — | $-51.7M | $-51.5M |
| FY2016 | $20.4M | $-69.7M | $-69.2M |
| FY2017 | $4.5M | $-79.6M | $-78.0M |
| FY2018 | $44.5M | $-72.7M | $-70.5M |
| FY2019 | $59.3M | $-69.1M | $-66.9M |
| FY2020 | $108.6M | $-29.0M | $-29.7M |
| FY2021 | $149.2M | $-12.5M | $-17.9M |
| FY2022 | $120.2M | $-55.6M | $-58.6M |
| FY2023 | $116.9M | $-20.5M | $-25.1M |
| FY2024 | $179.3M | $24.2M | $17.5M |
| FY2025 | $294.3M | $125.5M | $367.0M |